A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
Recruiting now
Conditions studied: Advanced Lung Cancer
In brief
This is a descriptive observational study in which data are collected in an epidemiological manner. This study is not intended to alter or interfere with the current medical practice of the enrolled patients. Data will be collected in a forward-looking manner. This is a descriptive observational study in which data are collected in an epidemiological manner. This study is not intended to alter or interfere with the current medical practice of the enrolled patients. Data from patients on prior treatment will be collected retrospectively, and data from patients who will be treated later and included in the study will be collected in a prospective manner. The criteria for retrospective collection were consistent with those for prospective collection. Eligible patients will be enrolled after NGS analysis of tumor tissue and informed consent has been obtained. Information required for the study will be collected (every 3 months).
Key facts
- Study ID
- NCT06183762
- Run by
- Hunan Province Tumor Hospital
- People needed
- 200
- Starts
- 2020-01-01
- Expected to finish
- 2025-06-30
- Last updated by the study team
- 2024-09-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must be ≥18 years of age.
- Provision of fully informed consent prior to any study specific procedures.
- Histologically or cytologically confirmed, unresectable stage IIIB/IIIC or stage IV NSCLC.
- Genetic variants of tumor tissue detected by NGS.
You may not qualify if…
- None.
Where it is running
- Hunan Province Tumor Hospital — Changsha, Hunan, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.